These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11685486)

  • 1. Further optimisation of 99mTc-Nanocoll sentinel node localisation in carcinoma of the breast by improved labelling.
    Gommans GM; van Dongen A; van der Schors TG; Gommans E; Visser JF; Clarijs WW; de Waard JW; van de Bos J; Boer RO
    Eur J Nucl Med; 2001 Oct; 28(10):1450-5. PubMed ID: 11685486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc Nanocoll: a radiopharmaceutical for sentinel node localisation in breast cancer--in vitro and in vivo results.
    Gommans GM; Gommans E; van der Zant FM; Teule GJ; van der Schors TG; de Waard JW
    Appl Radiat Isot; 2009 Sep; 67(9):1550-8. PubMed ID: 19328701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of increased (99m)Tc/(99)Tc ratios on count rates in sentinel node procedures: a randomised study.
    Gommans GM; van der Zant FM; van der Schors TG; van Dongen A; Teule GJ; Clarijs WW; Langenhorst BL; de Waard JW
    Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1231-5. PubMed ID: 12827312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodology of 99mTc-Nanocoll sentinel node localisation in carcinoma of the breast.
    Bourgeois P; Leduc O; Belgrado JP; Leduc A
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):831-2; author reply 832-3. PubMed ID: 12029559
    [No Abstract]   [Full Text] [Related]  

  • 5. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
    Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
    Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer.
    Pijpers R; Meijer S; Hoekstra OS; Collet GJ; Comans EF; Boom RP; van Diest PJ; Teule GJ
    J Nucl Med; 1997 Mar; 38(3):366-8. PubMed ID: 9074519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
    Gherghe M; Bordea C; Blidaru A
    Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Less axillary dissection necessary due to sentinel node biopsy in patients with breast carcinoma].
    Meijer S; Collet GJ; Pijpers HJ; van Hattum L; Hoekstra OS
    Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2239-43. PubMed ID: 8984370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node identification with radiopharmaceuticals in patients with breast cancer: a comparison of 99mTc-tin colloid and 99mTc-phytate efficiency.
    Seok JW; Choi YS; Chong S; Kwon GY; Chung YJ; Kim BG; Park SJ
    Breast Cancer Res Treat; 2010 Jul; 122(2):453-7. PubMed ID: 20532977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
    Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
    Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of a preoperative compact imager, a hand-held gamma-camera for breast cancer sentinel node biopsy: final results of a prospective double-blind, clinical study.
    Kerrou K; Pitre S; Coutant C; Rouzier R; Ancel PY; Lebeaux C; Huchet V; Montravers F; Pascal O; Duval MA; Lefebvre F; Menard L; Uzan S; Charon Y; Barranger E
    J Nucl Med; 2011 Sep; 52(9):1346-53. PubMed ID: 21849400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer.
    Goyal A; Newcombe RG; Mansel RE; Chetty U; Ell P; Fallowfield L; Kissin M; Sibbering M;
    Eur J Cancer; 2005 Jan; 41(2):238-43. PubMed ID: 15661548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of dynamic imaging in sentinel lymph node biopsy in breast cancer.
    Lee AC; Keshtgar MR; Waddington WA; Ell PJ
    Eur J Cancer; 2002 Apr; 38(6):784-7. PubMed ID: 11937312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node identification in breast cancer patients.
    Fonti R; Limite G; Sodano A; Riccardi A; Forestieri P; De Cristofaro G; Pettinato G; Salvatore M
    Radiol Med; 2002 Apr; 103(4):370-7. PubMed ID: 12107387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
    Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
    Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
    J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SPECT-CT: a new tool for localisation of sentinel lymph nodes in breast cancer patients].
    Mucientes Rasilla J; Farge Balbín L; Cardona Arboniés J; Moreno Elola-Olaso A; Delgado-Bolton R; Izarduy Pereyra L; Rodríguez Rey C; Lapeña Gutiérrez L; González Maté A; Román Santamaría JM; Carreras Delgado JL
    Rev Esp Med Nucl; 2008; 27(3):183-90. PubMed ID: 18570860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimisation of 99mTc-Nanocoll sentinel node localisation in carcinoma of the breast.
    Gommans GM; Boer RO; van Dongen A; van der Schors TG; de Waard JW
    Eur J Nucl Med; 2000 Jun; 27(6):744. PubMed ID: 10901463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.